Thomas Frimurer

Title: The Innovations of Thomas Frimurer

Introduction

Thomas Frimurer is a notable inventor based in Hørsholm, Denmark. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target the CRTH2 receptor. His work is essential for advancing treatments for various allergic conditions.

Latest Patents

Frimurer holds a patent for "CRTH2 receptor ligands for medicinal uses." This patent describes compounds that are useful for treating diseases responsive to modulation of CRTH2 receptor activity, such as asthma, rhinitis, allergic airway syndrome, and allergic rhinobronchitis. The compounds are characterized by a specific formula that includes various functional groups and ring structures, which enhance their therapeutic potential.

Career Highlights

Frimurer is currently associated with 7Tm Pharma A/S, a company focused on innovative pharmaceutical solutions. His expertise in medicinal chemistry has been instrumental in the development of new therapeutic agents. With a patent portfolio that includes 1 patent, he continues to contribute to the advancement of medical science.

Collaborations

Throughout his career, Frimurer has collaborated with esteemed colleagues such as Thomas Högberg and Evi Kostenis. These partnerships have fostered a collaborative environment that enhances research and development efforts in the pharmaceutical industry.

Conclusion

Thomas Frimurer's work exemplifies the impact of innovative thinking in the field of medicine. His contributions to CRTH2 receptor ligands are paving the way for new treatments for allergic diseases. His ongoing efforts in collaboration with other experts further highlight the importance of teamwork in scientific advancements.